NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » NIZO identifies faecal microbiotia infants during first 12 weeks of life

Health claim building

Press
Release

NIZO identifies faecal microbiotia infants during first 12 weeks of life

Food research company NIZO, together with five partners, has characterised the faecal microbiota of breastfed infants and formula-fed infants at 17 time points during the first 12 weeks of life.

The frequent sampling and the use of different molecular technologies gave a very detailed description of the development of the microbiota during life’s early stages.

Microbiota development of breastfed compared to formula-fed infants proceeds according to similar developmental stages, but abundance of skin and breast milk associated microbes were increased in the gut microbiome of breastfed infants compared to formula-fed infants. The scientific report of this study was recently published.

www.nizo.com

Contact Health claim building

Health claim building